- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04869644
A Trial of Habit Formation Theory for Exercise in Older Adults
November 4, 2022 updated by: Karina Davidson, Northwell Health
A Personalized Trial Pilot to Test Habit Formation Theory for Low Intensity Physical Exercise in Older Adults
This personalized trial will evaluate the effects of five behavioral change techniques (BCTs) described in Habit Formation Theory (Goal setting, Action Planning, Self-Monitoring, Behavioral Practice/Rehearsal and Habit Formation) delivered by text message to enhance low-intensity walking by 2,000 more steps per day/5 days per week in healthy Northwell employees aged 45-75 years old.
Study Overview
Status
Completed
Conditions
Detailed Description
This pilot study uses a virtual, single-arm, personalized design to evaluate the effects of the five behavioral change techniques (BCTs) described in Habit Formation Theory (Goal Setting, Action Planning, Self-Monitoring, Behavioral Practice/Rehearsal and Habit Formation) delivered by text message to enhance low-intensity walking by 2,000 more steps per day/5 days per week in healthy Northwell employees aged 45-75 years old.
Up to sixty participants will complete a 12-week personalized trial of their walking behavior and assess all five behavioral change techniques described in habit formation theory.
Prior to beginning the trial, participants will be sent a Fitbit® activity tracking watch that monitors number of steps per day.
Participants will be instructed to wear the Fitbit device all day and night, even when they are sleeping.
The single-arm, personalized trial will be comprised of a 2-week baseline/screening phase and a 10-week intervention phase.
During the baseline phase, participant's baseline levels of physical activity (operationalized as average steps per day measured using the Fitbit device) and adherence to the trial protocol (operationalized as wearing the Fitbit device for a minimum of 10 hours per day and completing daily survey measure) will be assessed.
Participants who are adherent to the study protocol, defined as adherence to Fitbit use and survey measures on 80% or more days during baseline, will proceed to the intervention phase.
At the beginning of the intervention, participants will develop a walking plan with the goal of walking 2,000 more steps per day than their average levels of baseline activity (e.g., if you walked an average of 6,000 steps per day during baseline, the new goal would be 8,000).
The walking plan will include details about the day, time, and location of walking behavior.
Participants will commit to walking according to this plan 5 days per week (e.g., walking 8,000 steps per day on 5 planned days.
A time-sensitive text of all 5 BCTs will delivered to the participant when the context (e.g., day of week, time of day) that they pre-selected is encountered.
Participants will later receive a text message with a link to a secure survey in which they will note whether they engaged with the five behavioral change techniques which were prompted.
The goal of the intervention is to help participants make their walking behavior habitual and automatic.
Participants will be assessed in terms of their satisfaction with the personalized trial design, their Fitbit-measured daily steps, adherence to their walking plan, and the automaticity of their walking behavior.
After completion of the intervention phase, participants will be allowed to keep the Fitbit device.
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10022
- Center for Personalized Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Men and women who:
- Age 45 - 75 years old of age
- Fluent in English
- Employed in the Northwell Health system
- Community-dwelling
- Report they are in good general health, walk regularly and have never been informed by a clinician that it was not advisable/safe to participate in a low-intensity walking program
- Owns and can regularly access a smartphone capable of receiving text messages
- Owns and can regularly access an e-mail account
Exclusion Criteria for Factors that May Limit Adherence to Interventions or Affect Conduct of the Trial
- < 45 years old or > 75 years old
- Unable to speak/comprehend English
- Not employed in Northwell Health system
- Have self-reported poor health, limited mobility and/or have been advised by a clinician not to increase their low-intensity walking
- Pregnancy
- Previous diagnosis of a serious mental health condition or psychiatric disorder, such as bipolar disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention: Behavioral Change Techniques to encourage Habit Formation
Individuals will receive daily text messages with the goal of increasing daily walking by 2,000 more steps 5 days per week.
Participants will be enrolled for a baseline period lasting 2 weeks where their average daily activity level will be assessed using a Fitbit device to generate an average daily step counts.
Following completion of baseline, participants will be asked to generate a walking plan with the goal of walking an additional 2,000 steps above their baseline activity level on 5 days per week.
This walking plan will include details about day of the week, time of day, and location of walking.
Once participants have completed their walking plan, they will receive daily texts based on the 5 identified BCTs for the duration of the 10-week intervention.
All BCTs will be delivered daily.
The goal of the text messages will be to encourage habit formation for walking behavior.
|
Goal setting: set or agree on a goal defined in terms of behavior to be achieved.
Action planning: prompt detailed planning of performance of behavior (must include a setting [walking to the mailbox], frequency, duration, and intensity.
Self-Monitoring of behavior: establish a method for person to monitor and record their number of steps based on their Fitbit.
Behavioral rehearsal: prompt practice or rehearsal of walking one or more times in a context when the performance may not be necessary, in order to increase habit and skill.
Prompt rehearsal & repetition of walking 2,000 steps or more in the same context repeatedly so that the context elicits the behavior.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Automaticity Score.
Time Frame: Assessed daily via online survey for participants across the duration of the 10-week intervention. Daily assessments will be aggregated by week to generate weekly means for automaticity.
|
Automaticity of behavior is assessed by a 4-item questionnaire asking about the automaticity of participant's walking behavior using a 4-point Likert scale with responses ranging from "Strongly Disagree" to "Strongly Agree".
Items are summed together to form a total score ranging from 0 to 12, with higher scores indicating that participant's new walking behaviors have become more habitual and automatic.
Change in daily automaticity levels over the course of the intervention period will be examined until scores level out and reach a score of 8 or more on 7 consecutive days.
Participants will be judged to have reached an asymptote at this point in time.
The proportion of the sample that has achieved automaticity will be reported as a number with percentage [N(%)].
Time-to-event analyses will be conducting examining participant differences in reaching an asymptote for automaticity and overall time-to-event will represented using Kaplan-Meier curves.
|
Assessed daily via online survey for participants across the duration of the 10-week intervention. Daily assessments will be aggregated by week to generate weekly means for automaticity.
|
|
Participant Satisfaction With Personalized Trial Components.
Time Frame: Assessed once after completion of the study at 12 weeks.
|
Participants will rate their satisfaction with the Personalized Trial overall and with individual elements of the trial in a satisfaction survey developed for this trial.
Participants will rate 9 items assessing satisfaction with methods and process of the trial on a 4-point Likert scale with responses ranging from "0 - Not at all satisfied" to "3 - Very satisfied".
Higher scores indicate greater levels of satisfaction.
Means and standard deviations will be reported for each element of satisfaction.
|
Assessed once after completion of the study at 12 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Within-person Change in Daily Steps.
Time Frame: Steps will be assessed continuously via worn activity tracker and step counts will be reported daily.
|
Participant steps will be assessed continuously using a Fitbit mobile device.
Daily steps for participants will be aggregated by baseline and intervention phases to generate average daily steps in each phase.
Changes in daily steps between baseline and intervention phases will be compared using Generalized Linear Mixed Model analyses.
|
Steps will be assessed continuously via worn activity tracker and step counts will be reported daily.
|
|
Proportion of Days Adhering to Walking Habit.
Time Frame: Assessed once after completion of the study at 12 weeks.
|
This is assessed using a single yes/no item assessed daily asking participants "Did you walk according to your walking plan today?".
For each participant, we will identify the proportion of days during the 10-week intervention where the participant adhered to the walking plan.
Proportions of adherence will reported across all participants with means and standard deviations.
|
Assessed once after completion of the study at 12 weeks.
|
|
Participant Attitudes and Opinions Towards Personalized Trials.
Time Frame: Assessed once after the completion of the intervention period.
|
Participants will be asked via survey about their attitudes and opinions regarding the personalized trial implementation (e.g., Did the trial feel burdensome?).
Participants will rate items on a 7-point Likert scale with responses ranging from "0 - Strongly Disagree" to "6 - Strongly Agree".
Higher scores indicate greater levels of agreement.
Scores on each item will be reported with means and standard deviations.
|
Assessed once after the completion of the intervention period.
|
|
Participant Adherence to Self-Monitoring.
Time Frame: Assessed daily via online survey for participants across the duration of the 10 week intervention. Daily responses will be aggregated across the intervention to determine an overall proportion of days adherent self-monitoring of behavior.
|
This will be measured via a single survey item delivered following a participant's scheduled walking time asking them to record the number of steps they took on their walk.
Individuals who complete this item and record their steps will be judged to be adherent to self-monitoring of their walking behavior.
Participant adherence will be aggregated over the course of the 10-week intervention and will be reported as proportion of days adherent to self-monitoring.
Proportions of adherence will be reported across all participants with means and standard deviations.
|
Assessed daily via online survey for participants across the duration of the 10 week intervention. Daily responses will be aggregated across the intervention to determine an overall proportion of days adherent self-monitoring of behavior.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karina W Davidson, Northwell Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 26, 2021
Primary Completion (ACTUAL)
February 1, 2022
Study Completion (ACTUAL)
May 31, 2022
Study Registration Dates
First Submitted
April 18, 2021
First Submitted That Met QC Criteria
April 30, 2021
First Posted (ACTUAL)
May 3, 2021
Study Record Updates
Last Update Posted (ACTUAL)
November 30, 2022
Last Update Submitted That Met QC Criteria
November 4, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20-1182
- P30AG063786-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All collected IPD will be de-identified and pooled before sharing on the Open Science Framework, along with a data dictionary.
IPD Sharing Time Frame
The study protocol, including he statistical analysis plan, will be made available in addition to the informed consent form following completion of recruitment but prior to publication of any data from the current study.
De-identified, pooled individual participant data collection.
We anticipate this data to be available on the Open Science Framework platform indefinitely.
IPD Sharing Access Criteria
All data and supporting information will be stored on the Open Science Framework, a free web application with no access restrictions.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
Clinical Trials on Goal setting
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedObesity | CancerUnited States
-
Tzu-Ting HuangCompletedRisk Reduction Behavior | Reduce Risk of DementiaTaiwan
-
Hadassah Medical OrganizationRecruiting
-
Milton S. Hershey Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Enrolling by invitationOverweight and Obesity | Walking | Physical Inactivity | Self-regulation | Cognitive HealthUnited States
-
Universiteit LeidenCompletedFuture Orientation | Self-defeating Behavior | Future Self-identificationNetherlands
-
Klinik ValensCompletedShared Decision MakingSwitzerland
-
Hasselt UniversityFederal Public Service Health, Food Chain Safety and EnvironmentRecruiting
-
Marquette UniversityFroedtert HospitalRecruiting
-
Dartmouth-Hitchcock Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Milton S. Hershey Medical CenterChildren's Miracle NetworkCompleted